This independent HPLC lab test confirms Tirzepatide 35.65mg from NEXAPH at 99.849% purity. The analysis was conducted by Janoshik Labs on February 16, 2026.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.849% indicates minimal contamination and high-grade synthesis.
The full certificate of analysis is available for verification at www.janoshik.com with the unique key 6X5WYC6ND2FA.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.